Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Context Therapeutics
Recent news which mentions Context Therapeutics
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
August 10, 2023
Tickers
CNTX
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
June 13, 2023
Tags
Context Therapeutics
XNAS:CNTX
From
TheNewswire.com - RSS (Media)
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
June 08, 2023
Tickers
AMGN
BNTX
CNTX
Tags
AMGN
Context Therapeutics
Biotech
From
Benzinga
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
April 24, 2023
Tags
XNAS:CNTX
Context Therapeutics
From
TheNewswire.com - RSS (Media)
Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference
April 14, 2023
Tickers
CNTX
Tags
Penny Stocks
General
CNTX
From
Benzinga
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature'
February 10, 2023
Tickers
INNO
Tags
Dana Cipriano
Insurance
J/C/ Simeon
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
John H/ Johnson
NRX Pharmaceuticals Inc/
Insurance
From
Business Journals
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022
Tags
XNAS:CNTX
Context Therapeutics
From
TheNewswire.com - RSS (Media)
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
November 10, 2022
Tickers
CNTX
Tags
Context Therapeutics
Biotech
Integral Molecular
From
Benzinga
New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
August 17, 2022
Tickers
CNTX
Tags
Partner Content
Benzinga
Interview
From
Benzinga
Lab Notes: Wistar Institute gets $5M NCI grant extension; Aclaris expands management team
August 05, 2022
Tickers
INNO
Tags
Roundup
Biotech
Context Therapeutics
From
Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Pharmaceuticals
Joshua Asper
Medical Devices
From
Business Journals
What About Women? This Company Targets Female-Focused Cancers
January 31, 2022
Tickers
CNTX
Tags
Market News
Context Therapeutics
Biotech
From
Benzinga
Context Therapeutics raises $31M in fresh funding from stock sale
December 07, 2021
Tags
Martin Lehr
Context Therapeutics
Biotech
From
Business Journals
Lab Notes: CHOP-based brain tumor network gets NIH boost; Integral Molecular inks deal with Astrazeneca
November 05, 2021
Tickers
INNO
Tags
Jennifer Minai/Azary
Children's Hospital of Philadelphia
Adam Resnick
From
Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
October 29, 2021
Tickers
INNO
Tags
Biotech
Windtree Therapeutics Inc/
Context Therapeutics
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.